Bertrand Nyuykonge

10PUBLICATIONS
20CO-AUTHORS
Medical mycologyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 14, 2023
The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo.

Mickey Konings, Kimberly Eadie, Nikolaos Strepis

|Oct 23, 2023
Using (1,3)-β-D-glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis.

Bertrand Nyuykonge, Emmanuel E Siddig, Borna A Nyaoke

|Dec 30, 2022
Comparing the performance of the common used eumycetoma diagnostic tests.

Emmanuel Edwar Siddig, Bertrand Nyuykonge, Najwa Adam Mhmoud

|Oct 06, 2022
Wako β-D-glucan assay can be used to measure serum β-D-glucan in Sudanese patients to aid with diagnosis of eumycetoma caused by Madurella mycetomatis.

Bertrand Nyuykonge, Emmanuel Siddig, Najwa A Mhmoud

|Aug 25, 2022
Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.

Bertrand Nyuykonge, Emmanuel E Siddig, Najwa Adam Mhmoud

|Jul 14, 2022
Madurella mycetomatis grains within a eumycetoma lesion are clonal.

Bertrand Nyuykonge, Emmanuel Edwar Siddig, Mickey Konings

Pageof 2

Frequent Collaborators

9 joint publications

Wendy Wj van de Sande

6 joint publications

Ahmed Hassan Fahal

5 joint publications

Emmanuel Siddig

4 joint publications

Annelies Verbon